Bacteria are one of the main groups of organisms, which dynamically and closely participate
in human health and disease development. With the integration of chemical biotechnology …

Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Background & Aims Fecal microbiota transplantation (FMT) is recommended for treatment of
recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial …

Background Clostridioides difficile infection is an urgent antibiotic-associated health threat
with few treatment options. Microbiota restoration with faecal microbiota transplantation is an …

Background Faecal microbiota transplantation (FMT) is an emerging treatment modality, but
its current clinical use and organisation are unknown. We aimed to describe the clinical use …

Objectives Although causality remains to be established, targeting dysbiosis of the intestinal
microbiota by faecal microbiota transplantation (FMT) has been proposed as a novel …

The gastro-intestinal tract is an extensive organ involved in several activities, with a crucial
role in immunity. Billions of commensal and transient microorganisms, known as the gut …

Objective The underlying microbial basis, predictors of therapeutic outcome and active
constituent (s) of faecal microbiota transplantation (FMT) mediating benefit remain unknown …

During recent years the impact of microbial communities on the health of their host (being
plants, fish, and terrestrial animals including humans) has received increasing attention. The …

In fecal microbiota transplantation (FMT) against recurrent Clostridioides difficile infection
(CDI), clinical outcomes are usually determined after 8 weeks. We hypothesized that the …